FR2361900B1 - - Google Patents

Info

Publication number
FR2361900B1
FR2361900B1 FR7616040A FR7616040A FR2361900B1 FR 2361900 B1 FR2361900 B1 FR 2361900B1 FR 7616040 A FR7616040 A FR 7616040A FR 7616040 A FR7616040 A FR 7616040A FR 2361900 B1 FR2361900 B1 FR 2361900B1
Authority
FR
France
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
FR7616040A
Other languages
French (fr)
Other versions
FR2361900A1 (fr
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Syntex USA LLC
Original Assignee
Syntex USA LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Syntex USA LLC filed Critical Syntex USA LLC
Publication of FR2361900A1 publication Critical patent/FR2361900A1/fr
Application granted granted Critical
Publication of FR2361900B1 publication Critical patent/FR2361900B1/fr
Granted legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/007Pulmonary tract; Aromatherapy
    • A61K9/0073Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/008Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy comprising drug dissolved or suspended in liquid propellant for inhalation via a pressurized metered dose inhaler [MDI]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/58Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0043Nose
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J71/00Steroids in which the cyclopenta(a)hydrophenanthrene skeleton is condensed with a heterocyclic ring
    • C07J71/0005Oxygen-containing hetero ring
    • C07J71/0026Oxygen-containing hetero ring cyclic ketals
    • C07J71/0031Oxygen-containing hetero ring cyclic ketals at positions 16, 17

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Otolaryngology (AREA)
  • Pulmonology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Steroid Compounds (AREA)
FR7616040A 1975-05-27 1976-05-26 Nouvelle forme de flunisolide cristallise et ses applications a titre de medicament Granted FR2361900A1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US58130075A 1975-05-27 1975-05-27
US58130175A 1975-05-27 1975-05-27

Publications (2)

Publication Number Publication Date
FR2361900A1 FR2361900A1 (fr) 1978-03-17
FR2361900B1 true FR2361900B1 (cg-RX-API-DMAC7.html) 1979-04-13

Family

ID=27078279

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7616040A Granted FR2361900A1 (fr) 1975-05-27 1976-05-26 Nouvelle forme de flunisolide cristallise et ses applications a titre de medicament

Country Status (15)

Country Link
JP (1) JPS51144719A (cg-RX-API-DMAC7.html)
AT (1) AT357702B (cg-RX-API-DMAC7.html)
AU (1) AU506080B2 (cg-RX-API-DMAC7.html)
CA (1) CA1075228A (cg-RX-API-DMAC7.html)
DE (2) DE2624924C2 (cg-RX-API-DMAC7.html)
ES (1) ES448220A1 (cg-RX-API-DMAC7.html)
FR (1) FR2361900A1 (cg-RX-API-DMAC7.html)
GB (1) GB1525181A (cg-RX-API-DMAC7.html)
HK (1) HK8580A (cg-RX-API-DMAC7.html)
IL (1) IL49652A (cg-RX-API-DMAC7.html)
MX (1) MX3864E (cg-RX-API-DMAC7.html)
MY (1) MY8000275A (cg-RX-API-DMAC7.html)
NL (1) NL191234C (cg-RX-API-DMAC7.html)
NZ (1) NZ180946A (cg-RX-API-DMAC7.html)
SE (1) SE421426B (cg-RX-API-DMAC7.html)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK162530C (da) * 1979-05-21 1992-03-30 Syntex Corp Fremgangsmaade til fremstilling af en krystallinsk modifikation af flunisolid
ATE3774T1 (de) * 1980-05-02 1983-06-15 Schering Corporation Beclomethason-ester-solvate, verfahren zu ihrer herstellung und herstellung einer formulierung.
GB2127689B (en) * 1982-10-05 1986-07-09 Sandoz Ltd Calcitonin inhalation compositions
US4782047A (en) * 1986-05-22 1988-11-01 Syntex Pharmaceuticals International Ltd. Aqueous steroid formulations for nasal administration
US5707634A (en) * 1988-10-05 1998-01-13 Pharmacia & Upjohn Company Finely divided solid crystalline powders via precipitation into an anti-solvent
EP0437451B1 (en) * 1988-10-05 1993-06-09 The Upjohn Company Finely divided solid crystalline powders via precipitation into an anti-solvent
DE4003272A1 (de) 1990-02-03 1991-08-08 Boehringer Ingelheim Kg Neue treibgasmischungen und ihre verwendung in arzneimittelzubereitungen
PL186196B1 (pl) * 1995-06-27 2003-11-28 Boehringer Ingelheim Kg Bezpropelentowy preparat środka leczniczego, zastosowanie bezpropelentowego preparatu środka leczniczego
DE19653969A1 (de) * 1996-12-20 1998-06-25 Boehringer Ingelheim Kg Neue wässrige Arzneimittelzubereitung zur Erzeugung treibgasfreier Aerosole
US20010031244A1 (en) 1997-06-13 2001-10-18 Chiesi Farmaceutici S.P.A. Pharmaceutical aerosol composition
DZ2947A1 (fr) 1998-11-25 2004-03-15 Chiesi Farma Spa Inhalateur à compteur de dose sous pression.
BR0008650B1 (pt) * 1999-03-03 2010-12-28 dispositivo de transmissão via nasal.
IT1313553B1 (it) * 1999-07-23 2002-09-09 Chiesi Farma Spa Formulazioni ottimizzate costituite da soluzioni di steroidi dasomministrare per inalazione.
IT1317846B1 (it) 2000-02-22 2003-07-15 Chiesi Farma Spa Formulazioni contenenti un farmaco anticolinergico per il trattamentodella broncopneumopatia cronica ostruttiva.
HRP20021025B1 (hr) 2000-05-22 2013-11-22 Chiesi Farmaceutici S.P.A. Formulacije stabilnih farmaceutskih otopina za inhalatore s odmjerenom dozom pod tlakom
SI1273292T1 (en) 2001-07-02 2004-12-31 Chiesi Farmaceutici S.P.A. Optimised formulation of tobramycin for aerosolization
JP5238779B2 (ja) * 2003-04-25 2013-07-17 ロート製薬株式会社 点鼻剤
JP4632687B2 (ja) * 2003-04-25 2011-02-16 ロート製薬株式会社 点鼻剤
EP1595531A1 (en) 2004-05-13 2005-11-16 CHIESI FARMACEUTICI S.p.A. Stable pharmaceutical solution formulations for pressurized metered dose inhalers
WO2014145067A1 (en) * 2013-03-15 2014-09-18 Medicis Pharmaceutical Corporation Topical compositions of flunisolide and methods of treatment

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3126375A (en) 1964-03-24 Chioacyl
BE585432A (fr) * 1958-12-08 1960-06-08 American Cyanamid Co Stéroïdes fluorés.
US3282791A (en) 1965-08-17 1966-11-01 Merck & Co Inc Inhalation aerosol suspension of anhydrous disodium dexamethasone phosphate, propellents, and sorbitan trioleate
US3592930A (en) * 1968-07-19 1971-07-13 Syntex Corp Moisture-deterioratable topical medicaments,particularly anti-inflammatory steroids,in a substantially non-aqueous fatty alcohol-propylene glycol vehicle
DE2015300A1 (de) * 1969-04-01 1970-10-29 Syntex Corp., Panania;PM örtliche, entzündungshemmende Präparate und Verfahren zu ihrer Verwendung
GB1429184A (en) * 1972-04-20 1976-03-24 Allen & Hanburys Ltd Physically anti-inflammatory steroids for use in aerosols
DE2332663C2 (de) 1973-06-23 1986-07-31 Schering AG, 1000 Berlin und 4709 Bergkamen Verwendung von Kortikoid-Wirkstoffen zur Inhalationstherapie
US3934013A (en) 1975-02-21 1976-01-20 Syntex (U.S.A.) Inc. Pharmaceutical composition

Also Published As

Publication number Publication date
SE421426B (sv) 1981-12-21
ES448220A1 (es) 1977-11-01
IL49652A (en) 1979-05-31
SE7605927L (sv) 1976-11-28
GB1525181A (en) 1978-09-20
AU506080B2 (en) 1979-12-13
DE2624924A1 (de) 1977-12-15
DE2624924C2 (de) 1986-11-27
DE2661037C2 (cg-RX-API-DMAC7.html) 1989-04-06
MX3864E (es) 1981-08-26
NZ180946A (en) 1978-07-28
MY8000275A (en) 1980-12-31
HK8580A (en) 1980-03-14
IL49652A0 (en) 1976-07-30
CA1075228A (en) 1980-04-08
AU1430176A (en) 1977-12-01
NL191234C (nl) 1995-04-03
JPS6247880B2 (cg-RX-API-DMAC7.html) 1987-10-09
FR2361900A1 (fr) 1978-03-17
NL191234B (nl) 1994-11-01
JPS51144719A (en) 1976-12-13
ATA388376A (de) 1979-12-15
AT357702B (de) 1980-07-25
NL7605699A (nl) 1976-11-30

Similar Documents

Publication Publication Date Title
FR2361900B1 (cg-RX-API-DMAC7.html)
JPS553884B2 (cg-RX-API-DMAC7.html)
FR2305568B3 (cg-RX-API-DMAC7.html)
FR2335865B3 (cg-RX-API-DMAC7.html)
JPS5285796U (cg-RX-API-DMAC7.html)
FR2332960B3 (cg-RX-API-DMAC7.html)
JPS533343Y2 (cg-RX-API-DMAC7.html)
JPS5416642Y2 (cg-RX-API-DMAC7.html)
JPS5259760U (cg-RX-API-DMAC7.html)
JPS5185044A (cg-RX-API-DMAC7.html)
JPS5310303U (cg-RX-API-DMAC7.html)
JPS5190708U (cg-RX-API-DMAC7.html)
JPS51118574U (cg-RX-API-DMAC7.html)
JPS51133342U (cg-RX-API-DMAC7.html)
BG22019A1 (cg-RX-API-DMAC7.html)
CH605462A5 (cg-RX-API-DMAC7.html)
CH584450A5 (cg-RX-API-DMAC7.html)
CH588987A5 (cg-RX-API-DMAC7.html)
CH1279675A4 (cg-RX-API-DMAC7.html)
BG22960A1 (cg-RX-API-DMAC7.html)
CH602804A5 (cg-RX-API-DMAC7.html)
BG22528A1 (cg-RX-API-DMAC7.html)
BG22214A1 (cg-RX-API-DMAC7.html)
BG22122A1 (cg-RX-API-DMAC7.html)
CH589491A5 (cg-RX-API-DMAC7.html)

Legal Events

Date Code Title Description
TP Transmission of property
CC Supplementary protection certificate (spc) laid open to the public (law of 25 june 1990)

Free format text: 92C0217, 920519

CB Supplementary protection certificate (spc) granted (law of 25 june 1990)

Free format text: 92C0217, 760526

CL Concession to grant licences